# Phase 4 infections trials recruiting: 102 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 102 trials in phase 4 for infections that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 infections trials: 102 rows for $5.10, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/infections

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 102
- Recruiting or not yet: 102
- Read on: November 19, 2026

## Trials

The 25 newest of 102, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07932132 | Immunogenicity and Safety of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Patients Infected With Human Immunodeficiency Virus (HIV) | Liaoning Chengda Biotechnology CO., LTD | Phase 4 | Recruiting | Rabies, HIV Infections | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932132) |
| November 9, 2026 | NCT07925255 | Daily, Weekly, or Event-driven Doxycycline for STI Prevention Among Men Who Have Sex With Men (MSM) Engaging in Chemsex: The DOSE... | University of California, Los Angeles | Phase 4 | Not yet recruiting | Gonorrhea, Chlamydia, Syphilis | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925255) |
| October 26, 2026 | NCT07895823 | Reaching Persons With HIV Who Are Out of Care Through Expedited Access to Long-Acting Injectable Antiretroviral Therapy - The RELAI Study | University of North Carolina, Chapel Hill | Phase 4 | Not yet recruiting | HIV Infection | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895823) |
| October 21, 2026 | NCT07885371 | Single-center, Open-label Study: Immunogenicity and Safety Observation After Vaccination With ACYW135 Meningococcal Polysaccharide Vaccine... | Zhejiang Provincial Center for Disease Control and Prevention | Phase 4 | Not yet recruiting | Meningococcal Disease; Meningococcal Meningitis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885371) |
| October 7, 2026 | NCT07863635 | A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations | ModernaTX, Inc. | Phase 4 | Recruiting | SARS-CoV-2 | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863635) |
| September 17, 2026 | NCT07824167 | The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation | Emory University | Phase 4 | Not yet recruiting | RSV Infection | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824167) |
| July 28, 2026 | NCT07730450 | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age | BioNTech SE | Phase 4 | Recruiting | COVID-19 Vaccines | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730450) |
| July 22, 2026 | NCT07720037 | Efficacy Comparison of 10-Day High-Dose Versus 14-Day Standard-Dose Vonoprazan Plus Amoxicillin in Helicobacter Pylori Eradication: A... | Shandong University | Phase 4 | Not yet recruiting | Helicobacter Infection, Vonoprazan, Amoxicillin | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07720037) |
| July 1, 2026 | NCT07678268 | Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir... | Instituto Mexicano del Seguro Social | Phase 4 | Recruiting | HIV Infection, Antiretroviral Therapy, Lentivirus Infections | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07678268) |
| June 8, 2026 | NCT07631377 | The LalelaLung Study: Digital Stethoscope Clinical Evaluation | Johns Hopkins University | Phase 4 | Not yet recruiting | Pneumonia, Tuberculosis, Pulmonary, Respiratory Tract Infections, Bronchiolitis, Respiratory Sounds, Antibiotic... | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07631377) |
| May 11, 2026 | NCT07578012 | Prevention With Ismigen of RTIs in Kids | Lallemand Pharma AG | Phase 4 | Recruiting | Respiratory Tract Infections (RTI), Healthy Children | 224 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07578012) |
| May 6, 2026 | NCT07571135 | Letermovir vs Valganciclovir in CMV R+ Kidney Transplant | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | CMV Infection, CMV, CMV Viremia, CMV Disease | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07571135) |
| May 6, 2026 | NCT07570433 | HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | CMV Infection | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570433) |
| May 6, 2026 | NCT07569653 | Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. | Sponsor not shown (see the record) | Phase 4 | Recruiting | Cytomegalovirus Infections, Cytomegalovirus Disease, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569653) |
| April 29, 2026 | NCT07556107 | The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS) | Bassett Healthcare | Phase 4 | Recruiting | Infection, Acute Kidney Injury, Sepsis | 852 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07556107) |
| April 23, 2026 | NCT07547826 | Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different... | Assiut University | Phase 4 | Not yet recruiting | Hydrocephalus, Ventriculoperitoneal Shunt Infection, Surgical Site Infection (SSI), Cerebrospinal Fluid Shunt... | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07547826) |
| April 16, 2026 | NCT07532941 | Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course' | Murdoch Childrens Research Institute | Phase 4 | Recruiting | Urinary Tract Infection, Cellulitis, Respiratory Tract Infections, Lymphadenitis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07532941) |
| April 14, 2026 | NCT07526948 | Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV | Albert Einstein College of Medicine | Phase 4 | Not yet recruiting | Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related... | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07526948) |
| April 2, 2026 | NCT07508124 | Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study | Baylor College of Medicine | Phase 4 | Recruiting | Urinary Tract Infection | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07508124) |
| March 30, 2026 | NCT07501065 | Prophylactic Antibiotics for Outpatient Urethral Bulking | University of Miami | Phase 4 | Recruiting | Urinary Tract Infections, Stress Urinary Incontinence, Urinary Incontinence | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07501065) |
| March 20, 2026 | NCT07484633 | A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients | Semmelweis University | Phase 4 | Recruiting | Infection, Sepsis, NICU, PICU, Beta Lactams | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07484633) |
| March 18, 2026 | NCT07479394 | Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old | Hasanuddin University | Phase 4 | Not yet recruiting | Respiratory Tract Infections (RTI) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07479394) |
| March 17, 2026 | NCT07478484 | Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB | Sponsor not shown (see the record) | Phase 4 | Recruiting | Ceftazidime-avibactam, Aztreonam, Gram-negative Bacterial Infection, Metallo-β-lactamase-producing, Carbapenem-resistant | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07478484) |
| March 17, 2026 | NCT07476339 | REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE | CAN Community Health | Phase 4 | Recruiting | HIV -1 Infection, HIV (Human Immunodeficiency Virus), HIV, HIV 1 Infection | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476339) |
| March 12, 2026 | NCT07465432 | Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries | University of Tennessee | Phase 4 | Recruiting | Drug Clearance After Severe Burn Injury | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465432) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Mahidol University | 3 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 |
| Murdoch Childrens Research Institute | 3 |
| [ModernaTX, Inc.](https://specstream.ai/data/clinical-trials/company/modernatx-inc) | 2 |
| Instituto Mexicano del Seguro Social | 2 |
| Telethon Kids Institute | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| University of Virginia | 1 |
| Ottawa Hospital Research Institute | 1 |
| National Center for AIDS/STD Control and Prevention, China CDC | 1 |
| CAN Community Health | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Bassett Healthcare | 1 |
| Precigen, Inc | 1 |
| University Hospital, Akershus | 1 |
| Duke University | 1 |
| Bangrak STIs Center | 1 |
| Central South University | 1 |
| Samsung Medical Center | 1 |
| Radboud University Medical Center | 1 |
| University of Oxford | 1 |
| Oswaldo Cruz Foundation | 1 |
| Hasanuddin University | 1 |
| University of Manitoba | 1 |
| Labo'Life | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 35 |
| Canada | 7 |
| China | 7 |
| Australia | 6 |
| France | 4 |
| Thailand | 4 |
| Sweden | 4 |
| Mexico | 4 |
| Spain | 4 |
| Switzerland | 3 |
| Netherlands | 3 |
| Israel | 3 |
| Denmark | 2 |
| Norway | 2 |
| United Kingdom | 2 |
| Croatia | 2 |
| New Zealand | 2 |
| Italy | 2 |
| Sierra Leone | 1 |
| Timor-Leste | 1 |
| Brazil | 1 |
| Belgium | 1 |
| Tanzania | 1 |
| Germany | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Bistros in the United States](https://specstream.ai/data/businesses/bistros/united-states)
- [Ferry boat companies in the United States](https://specstream.ai/data/businesses/ferry-boat-companies/united-states)
- [Mediterranean restaurants in the United States](https://specstream.ai/data/businesses/mediterranean-restaurants/united-states)
- [Software development companies in the United States](https://specstream.ai/data/businesses/software-development-companies/united-states)
- [B2B food products companies in the United States](https://specstream.ai/data/businesses/b2b-food-products-companies/united-states)
- [Educational research institutes in the United States](https://specstream.ai/data/businesses/educational-research-institutes/united-states)
